IL31 and primary cutaneous T-cell non-Hodgkin lymphoma: Previous studies have suggested the involvement of IL-31 in itching diseases including atopic dermatitis (AD) [30–39], other pathological conditions [40–45], drug-induced itch [46], and neoplastic diseases, such as CTCL [47–53].